Assessment of the Cyberlink Control System for Use by the ALS Patient

Study Purpose:

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Study Status:

Not recruiting

Disease:

Amyotrophic Lateral Sclerosis , Neurodegenerative Disease , Motor Neuron Disease

Study Type:

Observational

Type of Intervention:

N/A

Intervention Name:

N/A

Placebo:

N/A

Phase:

N/A

Study Chair(s)/Principal Investigator(s):

Terry Heiman-Patterson, MD, MDA/ALS Center of Hope

Clinicaltrials.gov ID:

NCT00718016

Neals Affiliated?

No

Coordinating Center Contact Information

MDA/ALS Center of Hope

Philadelphia, Pennsylvania, 19104 United States

Full Study Summary:

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Study Sponsor:

Drexel University College of Medicine

Estimated Enrollment:

1

Estimated Study Start Date:

11 / 30 / 2004

Estimated Study Completion Date:

04 / 01 / 2009

Posting Last Modified Date:

03 / 05 / 2013

Date Study Added to neals.org:

07 / 18 / 2008

Minimum Age:

18 Years

Maximum Age:

75 Years

Can participants use Riluzole?

Yes

Inclusion Criteria:

- Those aged 18-75 diagnosed with probable or definite ALS.

Exclusion Criteria:

- Those with decision impairment will not be considered.

MDA/ALS Center of Hope

Philadelphia, Pennsylvania 19104
United States